Xie Hao-Jun, Zhang Xu, Wei Zhen-Qiang, Long Hao, Rong Tie-Hua, Su Xiao-Dong
Department of Thoracic Surgery, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfeng Rd. East, Guangzhou, 510060, Guangdong, P. R. China.
Lung Cancer Institute, Sun Yat-Sen University, Guangzhou, 510060, Guangdong, P. R. China.
Chin J Cancer. 2017 Jan 10;36(1):7. doi: 10.1186/s40880-016-0170-7.
Body mass index (BMI) has a U-shaped association with lung cancer risk. However, the effect of BMI on prognosis is controversial. This retrospective study aimed to investigate the effect of BMI on the survival of patients with stage I non-small cell lung cancer (NSCLC) after surgical resection.
In total, 624 consecutive stage I NSCLC patients who underwent radical resection were classified into four groups according to their BMI: underweight (BMI < 18.5 kg/m), normal weight (BMI = 18.5-22.4 kg/m), overweight (BMI = 22.5-28.0 kg/m), and obese (BMI > 28.0 kg/m). The effect of BMI on progression-free survival (PFS) and overall survival (OS) was estimated using the Kaplan-Meier method and Cox proportional hazards model. Postoperative complications in each group were analyzed using the Chi square test or Fisher's exact test.
A univariate analysis showed that PFS and OS were longer in the overweight group than in other groups (both P < 0.05). A multivariate analysis showed that OS was longer in the overweight group than in other groups (compared with the other three groups in combination: hazard ratio [HR] = 1.87, 95% confidence interval [CI] 1.30-2.68, P = 0.003; compared with the underweight group: HR = 2.24, 95% CI 1.18-4.25, P = 0.013; compared with the normal weight group: HR = 1.58, 95% CI 1.07-2.33, P = 0.022; compared with the obese group: HR = 2.87, 95% CI 1.48-5.59, P = 0.002), but PFS was similar among the groups (HR = 1.28, 95% CI 0.97-1.68, P = 0.080). A subgroup analysis showed an association between being overweight and prolonged OS in patients at stage T1a (P = 0.024), T1b (P = 0.051), and T2a (P = 0.02), as well as in patients with a non-smoking history (P = 0.001). Overweight patients had lower rates of postoperative complications, such as respiratory failure (compared with the underweight and obese groups: P = 0.014), myocardial infarction (compared with the obese group: P = 0.033), and perioperative death (compared with the other three groups: P = 0.016).
Preoperative BMI is an independent prognostic factor for stage I NSCLC patients after resection, with overweight patients having a favorable prognosis.
体重指数(BMI)与肺癌风险呈U型关联。然而,BMI对预后的影响存在争议。这项回顾性研究旨在探讨BMI对I期非小细胞肺癌(NSCLC)患者手术切除后生存的影响。
总共624例接受根治性切除的连续I期NSCLC患者根据其BMI分为四组:体重过轻(BMI<18.5kg/m)、正常体重(BMI=18.5-22.4kg/m)、超重(BMI=22.5-28.0kg/m)和肥胖(BMI>28.0kg/m)。使用Kaplan-Meier法和Cox比例风险模型评估BMI对无进展生存期(PFS)和总生存期(OS)的影响。每组术后并发症采用卡方检验或Fisher精确检验进行分析。
单因素分析显示,超重组的PFS和OS比其他组更长(均P<0.05)。多因素分析显示,超重组的OS比其他组更长(与其他三组合并比较:风险比[HR]=1.87,95%置信区间[CI]1.30-2.68,P=0.003;与体重过轻组比较:HR=2.24,95%CI 1.18-4.25,P=0.013;与正常体重组比较:HR=1.58,95%CI 1.07-2.33,P=0.022;与肥胖组比较:HR=2.87,95%CI 1.48-5.59,P=0.002),但各组间PFS相似(HR=1.28,95%CI 0.97-1.68,P=0.080)。亚组分析显示,在T1a期(P=0.024)、T1b期(P=0.051)和T2a期(P=0.02)患者以及无吸烟史患者中,超重与OS延长相关(P=0.001)。超重患者术后并发症发生率较低,如呼吸衰竭(与体重过轻和肥胖组比较:P=0.014)、心肌梗死(与肥胖组比较:P=0.033)和围手术期死亡(与其他三组比较:P=0.016)。
术前BMI是I期NSCLC患者切除术后的独立预后因素,超重患者预后良好。